Vamorolone 4% suspension for oral dosing    (DrugBank: Vamorolone)

1 disease
告示番号疾患名(ページ内リンク)臨床試験数
97潰瘍性大腸炎1

97. 潰瘍性大腸炎 [臨床試験数:2,269,薬物数:1,331(DrugBank:241),標的遺伝子数:114,標的パスウェイ数:181
Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2,269 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04348890
(ClinicalTrials.gov)
September 1, 202013/4/2020Proof of Concept Trial of Vamorolone in Pediatric Ulcerative ColitisA Phase I/II Open-Label, Proof-of-Concept Study of Vamorolone in Children and Adolescents With Mild-Moderately Active Ulcerative ColitisPediatric Ulcerative ColitisDrug: Vamorolone 4% suspension for oral dosingReveraGen BioPharma, Inc.NULLWithdrawn4 Years17 YearsAll0Phase 1;Phase 2NULL